{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAn embodiment of the invention has an affinity for human CEACAM5 or Macaca fascicularis CEACAM5, or both, which is <10nM, for instance < 5nM, < 3nM, < 1 nM or < 0.1 nM, for instance an affinity of 0.01 nM to 5 nM, or and affinity of 0.1 nM to 5 nM, or of 0.1 nM to 1 nM.\nThe antibody of the invention may also have an apparent dissociation constant (apparent KD), as may be determined by FACS analysis on tumor cell line MKN45 (DSMZ, ACC 409) or on xenograft tumor cells deriving from patient (CR-IGR-034P available from Oncodesign Biotechnology, tumor collection CReMEC), which is <25nM, for instance <20nM, <10nM, <5nM, <3nM or <1 nM.\nAffinity for human CEACAM5 or for Macaca fascicularis CEACAM5 may be determined as the EC50 value in an ELISA using soluble recombinant CEACAM5 as capture antigen. \nThe apparent KD may be within the range 0.01 -20 nM, or may be within the range 0.1 -20nM, 0.1 -10nM, or 0.1 - 5nM."}
{"final_json": [{"molecule_name": "CEACAM5", "protein_target_name": "CEACAM5", "binding_metric": null, "value": "<10", "unit": "nM"}, {"molecule_name": "CEACAM5", "protein_target_name": "CEACAM5", "binding_metric": null, "value": "<5", "unit": "nM"}, {"molecule_name": "CEACAM5", "protein_target_name": "CEACAM5", "binding_metric": null, "value": "<3", "unit": "nM"}, {"molecule_name": "CEACAM5", "protein_target_name": "CEACAM5", "binding_metric": null, "value": "<1", "unit": "nM"}, {"molecule_name": "CEACAM5", "protein_target_name": "CEACAM5", "binding_metric": null, "value": "<0.1", "unit": "nM"}, {"molecule_name": "CEACAM5", "protein_target_name": "CEACAM5", "binding_metric": null, "value": "0.01-5", "unit": "nM"}, {"molecule_name": "CEACAM5", "protein_target_name": "CEACAM5", "binding_metric": null, "value": "0.1-5", "unit": "nM"}, {"molecule_name": "CEACAM5", "protein_target_name": "CEACAM5", "binding_metric": null, "value": "0.1-1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "KD", "value": "<25", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "KD", "value": "<20", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "KD", "value": "<10", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "KD", "value": "<5", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "KD", "value": "<3", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "KD", "value": "<1", "unit": "nM"}, {"molecule_name": "CEACAM5", "protein_target_name": "CEACAM5", "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "KD", "value": "0.01-20", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "KD", "value": "0.1-20", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "KD", "value": "0.1-10", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "KD", "value": "0.1-5", "unit": "nM"}]}
{"raw_mentions": "Affinity to human and cynomolgus CEACAM5 was verified by ELISA, EC50 are provided on Table 13.\nThe binding kinetics of humanized anti-CEACAM5_MAb2 variants, compared with chimeric MAb2, to recombinant human CEACAM5 (hCEACAM5) and cynomolgus monkey CEACAM5 (cCEACAM5) were determined by surface plasmon resonance assay using a BIAcore 2000 (BIAc \nSpecificity to human CEACAM5 versus human CEACAM1 , CEACAM6, CEACAM7 and CEACAM8 was verified by ELISA. It was reported as the percentage of binding compared to full binding with human CEACAM5, see Table 14.\nEpitope binding domain was verified by ELISA and showed that humanized variants recognized the A3-B3 domain specifically. It was reported as the percentage of binding compared to full binding with human CEACAM5 on Table 15."}
{"final_json": [{"molecule_name": null, "protein_target_name": "CEACAM5", "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": "humanized anti-CEACAM5_MAb2 variants", "protein_target_name": "CEACAM5", "binding_metric": null, "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": "CEACAM5", "binding_metric": null, "value": null, "unit": "%"}, {"molecule_name": "humanized variants", "protein_target_name": "CEACAM5", "binding_metric": null, "value": null, "unit": "%"}]}
